U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C16H21N
Molecular Weight 227.3446
Optical Activity ( - )
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MORPHINAN

SMILES

C1CC[C@]23CCN[C@H](CC4=C2C=CC=C4)[C@@H]3C1

InChI

InChIKey=INAXVFBXDYWQFN-XHSDSOJGSA-N
InChI=1S/C16H21N/c1-2-6-13-12(5-1)11-15-14-7-3-4-8-16(13,14)9-10-17-15/h1-2,5-6,14-15,17H,3-4,7-11H2/t14-,15+,16-/m0/s1

HIDE SMILES / InChI

Molecular Formula C16H21N
Molecular Weight 227.3446
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Harnessing biodiversity: the Malagasy Institute of Applied Research (IMRA).
2010-12-13
Integration of deep transcriptome and proteome analyses reveals the components of alkaloid metabolism in opium poppy cell cultures.
2010-11-18
Total synthesis of (-)-morphine.
2010-10-04
Interactive effects of endogenous morphine, nitric oxide, and ethanol on mitochondrial processes.
2010-10
In vitro and in vivo pharmacological profile of the 5-benzyl analogue of 14-methoxymetopon, a novel mu opioid analgesic with reduced propensity to alter motor function.
2010-09-11
Biological indications of a novel "short" µ opiate receptor in domestic chicken.
2010-08-30
Morphinans and isoquinolines: acetylcholinesterase inhibition, pharmacophore modeling, and interaction with opioid receptors.
2010-07-15
Hasubanan alkaloids with delta-opioid binding affinity from the aerial parts of Stephania japonica.
2010-05-28
Straightforward assembly of the octahydroisoquinoline core of morphinan alkaloids.
2010-05-21
Biochemistry and occurrence of o-demethylation in plant metabolism.
2010
Molecular characterization of O-methyltransferases involved in isoquinoline alkaloid biosynthesis in Coptis japonica.
2010
Univalent and bivalent ligands of butorphan: characteristics of the linking chain determine the affinity and potency of such opioid ligands.
2009-12-10
Endogenous morphine and nitric oxide coupled regulation of mitochondrial processes.
2009-12
Visualisation and quantitative analysis of the rodent malaria liver stage by real time imaging.
2009-11-18
Synthesis and SAR study of opioid receptor ligands: mono- and bis-indolomorphinans.
2009-10
Evolution of morphine biosynthesis in opium poppy.
2009-05-07
7α-Methoxy-carbonyl-6,7,8,14-tetra-hydro-6,14-endo-ethenothebaine.
2009-03-25
Recent developments in the chemistry of thebaine and its transformation products as pharmacological targets.
2009
Bisbenzylisoquinoline alkaloids from Cocculus pendulus.
2009
NADPH oxidase as a therapeutic target in Alzheimer's disease.
2008-12-03
Synthesis of a stable iminium salt and propellane derivatives.
2008-10-17
The presence of endogenous morphine signaling in animals.
2008-10
Production of benzylisoquinoline alkaloids in Saccharomyces cerevisiae.
2008-09
Quantitative 1H nuclear magnetic resonance metabolite profiling as a functional genomics platform to investigate alkaloid biosynthesis in opium poppy.
2008-08
Concise synthesis of dimemorfan (DF) starting from 3-hydroxymorphinan (3-HM).
2008-07
Isolation and antimalarial activity of new morphinan alkaloids on Plasmodium yoelii liver stage.
2008-06-01
Syntheses of 4,6'-epoxymorphinan derivatives and their pharmacologies.
2008-04-15
Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2.
2008-03-21
MLR-ANN and RTO approach to mu-opioid receptor-binding affinity. Pooling data from different sources.
2008-03
Enhancement of alkaloid production in opium and California poppy by transactivation using heterologous regulatory factors.
2008-02
Morphinane alkaloid dimers from Sinomenium acutum.
2008-01
Metabolic engineering of morphinan alkaloids by over-expression and RNAi suppression of salutaridinol 7-O-acetyltransferase in opium poppy.
2008-01
Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activation.
2008
Antidepressant-like effects of the novel kappa opioid antagonist MCL-144B in the forced-swim test.
2008
Persistence of evolutionary memory: primordial six-transmembrane helical domain mu opiate receptors selectively linked to endogenous morphine signaling.
2007-12
Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase.
2007-09-19
QSAR study on the antinociceptive activity of some morphinans.
2007-07
In-vitro investigation of oxazol and urea analogues of morphinan at opioid receptors.
2007-06-15
High-affinity carbamate analogues of morphinan at opioid receptors.
2007-03-15
Levorphanol: the forgotten opioid.
2007-03
Increasing morphinan alkaloid production by over-expressing codeinone reductase in transgenic Papaver somniferum.
2007-01
Poppy alkaloid profiling by electrospray tandem mass spectrometry and electrospray FT-ICR mass spectrometry after [ring-13C6]-tyramine feeding.
2007-01
Drug development papers in PLoS Medicine: how we try to spot a winner.
2006-12
A plant-derived morphinan as a novel lead compound active against malaria liver stages.
2006-12
Total synthesis of (+/-)-morphine.
2006-11-09
Comparative transcript and alkaloid profiling in Papaver species identifies a short chain dehydrogenase/reductase involved in morphine biosynthesis.
2006-10
Non-competitive inhibitory activities of morphinan and morphine derivatives at the alpha 3 beta 4 Neuronal nicotinic acetylcholine receptor determined using nonlinear chromatography and chemometric techniques.
2006-09
Opium Poppy (Papaver somniferum).
2006
Methods for regeneration and transformation in Eschscholzia californica: A model plant to investigate alkaloid biosynthesis.
2006
Formic acid catalysed rearrangement of 5beta-methyldihydrothevinols (= 3,6-dimethoxy-5,17-dimethyl-4,5-epoxy-6,14-ethanomorphinan-7-methanols): synthesis of new doubly bridged morphinan derivatives.
2005-02
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 20:46:43 GMT 2025
Edited
by admin
on Mon Mar 31 20:46:43 GMT 2025
Record UNII
O97T9O1050
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MORPHINAN
MI  
Systematic Name English
(9.BETA.,13.BETA.,14.BETA.)-MORPHINAN
Preferred Name English
MORPHINAN, (-)-
Systematic Name English
(4AR-(4A.ALPHA.,10.ALPHA.,10A.ALPHA.))-1,3,4,9,10,10A-HEXAHYDRO-2H-10,4A-(IMINOETHANO)PHENANTHRENE
Systematic Name English
MORPHINANE
Systematic Name English
(-)-MORPHINAN
Systematic Name English
(4AR,10R,10AR)-1,3,4,9,10,10A-HEXAHYDRO-2H-10,4A-(IMINOETHANO)PHENANTHRENE
Systematic Name English
MORPHINAN [MI]
Common Name English
Code System Code Type Description
MERCK INDEX
m7630
Created by admin on Mon Mar 31 20:46:43 GMT 2025 , Edited by admin on Mon Mar 31 20:46:43 GMT 2025
PRIMARY Merck Index
PUBCHEM
6857497
Created by admin on Mon Mar 31 20:46:43 GMT 2025 , Edited by admin on Mon Mar 31 20:46:43 GMT 2025
PRIMARY
FDA UNII
O97T9O1050
Created by admin on Mon Mar 31 20:46:43 GMT 2025 , Edited by admin on Mon Mar 31 20:46:43 GMT 2025
PRIMARY
EPA CompTox
DTXSID00425890
Created by admin on Mon Mar 31 20:46:43 GMT 2025 , Edited by admin on Mon Mar 31 20:46:43 GMT 2025
PRIMARY
CAS
468-10-0
Created by admin on Mon Mar 31 20:46:43 GMT 2025 , Edited by admin on Mon Mar 31 20:46:43 GMT 2025
PRIMARY
CHEBI
35649
Created by admin on Mon Mar 31 20:46:43 GMT 2025 , Edited by admin on Mon Mar 31 20:46:43 GMT 2025
PRIMARY
Related Record Type Details
RACEMATE -> ENANTIOMER
SALT/SOLVATE -> PARENT